Recently published Non-muscle Invasive Bladder Cancer Market Insights report includes a comprehensive understanding of ...
At diagnosis, urothelial cancer is categorized as either non-muscle-invasive bladder cancer (NMIBC; stages Tis, Ta and T1) or muscle-invasive bladder cancer (MIBC; stages T2–T4) when the disease has ...
Therapeutic progress has accelerated, with multiple recent approvals improving outcomes across early-stage, muscle-invasive, and metastatic urothelial carcinoma. FGFR3 and HER2 protein expression by ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
For people with non–muscle invasive bladder cancer (NMIBC), the reality can be especially pronounced. The disease is often persistent, requiring repeated treatments, frequent monitoring, and ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results